Skip to main content

SaMD

By Joost Bruggeman | 03:09 am | July 10, 2020
The global workforce need the right tools as they continue to engage one of the greatest threats of our time with the resurgence of the coronavirus in China and marked increase in positive cases found in the US, says Joost Bruggeman, co-founder and CEO of Siilo.
By Dave Muoio | 01:09 pm | June 04, 2019
At BIO 2019 in Philadelphia, a panel of industry experts discussed their experiences with the FDA's pilot program; ambiguities in drug, device and software pathways; and the hurdles digital health regulation has yet to properly address.
By Dave Muoio | 04:07 pm | May 22, 2019
Companies planning an upcoming De Novo or 510(k) submission for their software medical device are eligible, but participation will not yield precertification.